The U.S. Food and Drug Administration on Tuesday approved Sage Therapeutics Inc&...
- The U.S. Food and Drug Administration on Tuesday approved Sage Therapeutics Inc’s drug for postpartum depression, marking the first approval of a treatment specifically developed for the condition that affects a new mother’s ability to care for herself or her baby.
The drug, which is administered as a single 60-hour intravenous infusion, is chemically identical to the hormone allopregnanolone. In severe cases, the mother may have suicidal tendencies, may not want to nurse her child and might even harm the baby. Patients will be advised to avoid activities such as driving until feelings of sleepiness have gone away.
“I do not see Zulresso having significant uptake given the requirements for IV infusion and duration of the infusion,” Dr. Sanjay Mathew, a member of the Anxiety and Depression Association of America, told Reuters.
France Dernières Nouvelles, France Actualités
Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.
Sage Therapeutics’ Drug for Postpartum Depression Gets FDA NodU.S. health regulators on Tuesday approved Sage Therapeutics Inc.’s Zulresso, the first medication specifically intended for women with postpartum depression.
Lire la suite »
Sage stock rises after FDA approves first postpartum depression treatment Zulresso
Lire la suite »
Trump opens sage grouse habitat to oil and gas drillingThe Interior Department finalized changes to protections for the sage grouse bird, which could open lands in seven Western states to oil and gas drilling
Lire la suite »
Analysis | The Energy 202: Environmentalists rally to #SaveGrouse after Trump makes it easier to drill in habitatAnalysis: Environmentalists rally to SaveGrouse after Trump makes it easier to drill in habitat
Lire la suite »
College cheating scandal brings resignations and questions at elite prep schoolsSome of Southern California's most elite private schools are caught up in the national college admissions cheating scandal, including Sage Hill and Harvard Westlake.
Lire la suite »
Regulators just approved a new depression drug with the potential to be a game-changerUnlike the depression drugs available for decades, neither of the two new drugs is a pill. One is a nasal spray; the latest is an injection made by Sage.
Lire la suite »
Sage Therapeutics’ Drug for Postpartum Depression Gets FDA NodU.S. health regulators on Tuesday approved Sage Therapeutics Inc.’s Zulresso, the first medication specifically intended for women with postpartum depression.
Lire la suite »
Sage stock rises after FDA approves first postpartum depression treatment Zulresso
Lire la suite »